Blog

38 Articles

Pancreatic cancer survivors Scott and Steve Nelson
Survivor Stories
June 6, 2019 • 5 Min

Younger Brother’s Pancreatic Cancer Leads to Regular Screening for his Oldest Brother

When Scott Nelson was diagnosed with pancreatic cancer, oldest brother Steve began regular screening, which lead to his early diagnosis.

pancreatic cancer patient Rick Baker and his wife Shelley
Survivor Stories
May 10, 2019 • 5 Min

Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments

With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.

Gloria Peterson, Ph.D.
Research
February 4, 2019 • 5 Min

Genetic Testing for All Pancreatic Cancer Patients

A study by Dr. Gloria Petersen’s research team has led to an official recommendation that all pancreatic cancer patients get genetic testing.

pancreatic cancer patient Miriam Hermosa
Survivor Stories
January 30, 2019 • 6 Min

Choosing the Strongest Chemotherapy for Pancreatic Cancer

Miriam Hermosa decided to take advantage of her relatively good health and try pancreatic cancer treatment with FOLFIRINOX to get more time with her family.

Old medicine bottles
Research
January 22, 2019 • 4 Min

A PARP Inhibitor Approval for Pancreatic Cancer

PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.

Dr. Allyson Ocean
Research
January 9, 2019 • 6 Min

Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019

Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.

Dr. Sapna Syngal
Research
November 14, 2018 • 4 Min

New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients

Dr. Sapna Syngal discusses the new NCCN guidelines, which support genetic testing for all pancreatic cancer patients, because mutations can influence treatment.

Kim Reiss Binder
Research
November 1, 2018 • 5 Min

PARP Inhibitors for Pancreatic Cancer Maintenance Treatment

Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.

Doron Broman, center left, surrounded by others includ Dr. Kimmie Ng on the far right.
Survivor Stories
October 23, 2018 • 2 Min

Molecular Sequencing Leads to Customized Treatment

When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.

Roxanne Waling, five-year pancreatic cancer survivor posing on her river cruise through Europe.
Survivor Stories
May 9, 2018 • 6 Min

Listen to Your Body

When Roxanne Waling discovered she had pancreatic cancer she underwent genetic testing. She found she was a BRCA2 carrier, which influenced her post-treatment decisions about her health.

Marisa Harris
Survivor Stories
April 13, 2018 • 8 Min

Reimagining the Possible to Survive Stage IV Pancreatic Cancer

Marisa Harris was given a devastating diagnosis of stage IV pancreatic cancer. She tapped the power within herself, as well as chemotherapy, to become a long-term survivor.

pancreatic cancer patient Judith Glaser
Survivor Stories
December 21, 2017 • 5 Min

Using the Energy Around Me to Help Me Heal

Judith Glaser’s genetic mutation influenced her chemotherapy and radiation treatments, supported by the healing energy of friends.

Gloria Peterson, Ph.D.
Research
October 12, 2017 • 5 Min

Tumor Genetics Research Brings Some Answers for Families at High Risk

Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.

Pancreatic cancer survivor Steve Merlin
Survivor Stories
May 4, 2017 • 5 Min

A Clinical Trial Matches My Genetics

Steven Merlin learned that he carried the BRCA2 mutation after he developed pancreatic cancer. He researched and found a clinical trial for BRCA carriers.

Illustration of the twisting spirals of two DNA double helices in royal blue and purple on a turquoise colored background
Research
October 18, 2016 • 2 Min

A New Drug Combination to Control Advanced Pancreatic Cancer

A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.